Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...
Ambac (AMBC) faces a stock dip after Q4 earnings miss, but growth prospects remain strong with profitable underwriting and ...
Reports Q4 revenue $47.1M vs. $38.6M last year. A significant amount of the increase is attributable to the base rate increase in the Middlesex ...
Reports Q4 revenue $1.7B, consenus $1.94B. “As we advance toward the anticipated close of the acquisition by Boeing in mid-2025, we continue to ...
Progyny (PGNY -1.68%), a pioneer in fertility benefits management, released its earnings for the fourth quarter on Feb. 27.
Okta (OKTA) is scheduled to report its fourth quarter earnings result on Monday, March 3rd, after the closing bell. Wall ...
Owens & Minor beat Q4 EPS and revenue estimates, announced a $100M buyback, and provided 2025 guidance, projecting ...
Q4 2024 Earnings Call Transcript February 27, 2025 FIGS, Inc. reports earnings inline with expectations. Reported EPS is ...
FUBO earnings call for the period ending December 31, 2024. fuboTV ( FUBO -16.76%) Q4 2024 Earnings Call Feb 28, 2025, 8:30 a ...
21h
Zacks.com on MSNRecursion Pharmaceuticals (RXRX) Reports Q4 Loss, Lags Revenue EstimatesRecursion Pharmaceuticals (RXRX) delivered earnings and revenue surprises of -47.22% and 84.18%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results